„Morning or evening?” and „With food or on an empty stomach?” are among the most common practical questions regarding NAD+ precursors. However, studies specifically analyzing the timing of intake are much more limited than studies evaluating whether these compounds can affect NAD+-related biomarkers.
In this article, we discuss what is currently known about NAD+ and circadian biology, the impact of meals, combining it with resveratrol, and whether the importance of timing differs depending on the product form.
Morning or evening? What determines the right time?
There is a scientific rationale for investigating whether the time of day can affect NAD+ metabolism. Currently, however, this does not translate into a clearly established optimal time for taking NAD+ precursors.
Circadian rhythm rationale. Studies published in 2009 by two independent teams showed that NAD+ levels and the activity of NAMPT, an important enzyme in the NAD+ salvage pathway, oscillate over 24 hours in mice. These changes were linked to the core circadian clock components CLOCK and BMAL1. NAD+ also interacts with circadian rhythm regulation via the NAD+-dependent enzyme SIRT1, creating a feedback loop between cellular NAD+ metabolism and the molecular circadian clock [1].
These results confirmed a significant mechanistic link between NAD+ metabolism and circadian biological rhythms in animal models. They also provide a scientific rationale for further research into whether the timing of NAD+ precursor intake can influence biological responses.
What human study data actually show. Evidence from humans is more limited. One study used magnetic resonance spectroscopy to measure brain NAD levels in 25 healthy participants during morning and afternoon sessions. The researchers found no significant effect of the time of day on NAD levels in the studied brain region. However, salivary cortisol measurements confirmed that participants were evaluated in different physiological states related to the circadian rhythm [2].
This means that although animal studies indicate a circadian regulation of NAD+ metabolism at the mechanistic level, this human study found no significant difference between the morning and afternoon in terms of the measured levels of NAD in the brain.
What this means in practice: Current data from human studies do not confirm that taking an NAD+ precursor at one specific time of day produces significantly different effects than taking it at a different time.
The role of NAD+ in circadian rhythm biology is well documented at the mechanistic level, particularly in animal studies; however, this has not yet led to the establishment of a validated supplementation regimen for humans that specifies the optimal time of day. In practice, taking the product regularly at a consistent time may be more reasonable than assuming that morning or evening is biologically superior.
Should NAD+ be taken with food or on an empty stomach?
Studies directly comparing the intake of NAD+ precursors with food and on an empty stomach are limited. No controlled human study has been identified that directly compares these conditions to determine differences in absorption or efficacy.
Major published human studies on nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have typically not analyzed the timing of intake relative to meals as an independent experimental variable. Some studies have used standardized instructions regarding supplementation, including taking it in a specific relation to meals, but these studies were not designed to determine whether taking it after a meal or on an empty stomach is better.
The overall tolerability of the supplement may also be a factor. Taking an oral supplement with food can sometimes reduce gastrointestinal discomfort, but this does not automatically mean that food improves its absorption or biological activity. Some studies on NAD+ precursors have reported mild gastrointestinal symptoms.
Without direct comparative data, it cannot be stated that taking NAD+ precursors with food or on an empty stomach is consistently more effective. Individual tolerance and instructions for a specific formulation may therefore matter more than the assumption that one of these methods has been scientifically proven to be better.
Timing of administration when combined with resveratrol
NAD+ precursors and resveratrol are often discussed together, but it is important to distinguish between mechanistic rationale and clinical evidence from human studies.
The mechanistic rationale for investigating such a combination is partly related to sirtuin biology. Resveratrol is a polyphenolic compound studied in the context of SIRT1, while sirtuin enzymes require NAD+ for their enzymatic activity. This provides a biochemical rationale for investigating the interaction between compounds affecting NAD+ availability and substances associated with sirtuin pathways.
However, a mechanistic rationale does not mean that combining these substances provides additional clinical effects, nor that they must be taken at the same time.
What was actually studied in humans looks somewhat different. In one important published clinical trial, nicotinamide riboside was evaluated together with pterostilbene rather than resveratrol alone. Pterostilbene is chemically related to resveratrol, but has different pharmacokinetic properties. In this study, multiple administrations of the combination of NR and pterostilbene increased NAD+ levels over the study period. However, the timing of administration of the individual ingredients was not evaluated as an independent experimental variable [3].
This distinction matters because results concerning pterostilbene should not be automatically treated as direct evidence regarding resveratrol.
No dedicated published human clinical study has been identified that specifically evaluates the combination of an NAD+ precursor with resveratrol and compares whether taking these substances simultaneously or separately affects the outcomes.
Therefore, there is currently a lack of sufficient direct clinical data to determine the „best time” to take an NAD+ precursor together with resveratrol. Recommendations to take them at the same time or at different times would therefore go beyond the available evidence regarding administration timing.
Does the administration time differ depending on the oral, sublingual, and injection forms?
The significance of the timing of administration may vary depending on the formulation and route of administration, but evidence to determine the optimal time remains limited.
Oral capsules and tablets: Current human research data do not indicate an optimal time of day for oral NAD+ precursors. Multiple-dose studies show that NAD+-associated biomarkers can change during regular exposure, but do not prove that a specific administration time provides an advantage [4].
Sublingual forms: No adequate human studies have been conducted regarding the optimal time to take sublingual NAD+-related products. General rules for sublingual administration cannot be automatically applied to NAD+ products without studies on the absorption of the specific formulation. Therefore, claims that a specific interval relative to meals or beverages significantly improves NAD+ absorption require direct evidence.
Injection (intramuscular/subcutaneous) and intravenous forms: the timing of administration depends on the specific formulation, research protocol, or medically supervised use, rather than an established advantage of morning over evening. Published studies on intravenous NAD+ have used specific administration schedules, but it has not been demonstrated that the time of day is an independent factor influencing efficacy [5].
Injection and intravenous administration also involve different safety, sterility, pharmacokinetics, and regulatory issues than oral supplementation. Evidence regarding one route of administration should not be automatically extrapolated to another.
For all of these forms, available studies do not indicate a single, universal, optimal time of administration for NAD+-related products. Where multiple administrations were evaluated, adherence to a consistent study protocol has a much better scientific basis than claims regarding a specific time of day.
What happens if you take a product at the „wrong” time?
Current data does not indicate a specific period in the morning or evening as an „inappropriate” time to take an NAD+ precursor.
The available study on NAD levels in the human brain did not show a significant difference related to the time of day in the analyzed measurement [2]. Similarly, major studies on NAD+ precursors in humans generally did not identify the time of administration as a controlled variable responsible for differences in baseline results.
This does not mean that the timing of administration has no biological significance. Circadian rhythm studies clearly indicate that NAD+ metabolism is linked to the molecular clock [1]. Rather, it means that current human supplementation studies have not yet established whether deliberately altering the timing of administration produces clinically significant differences.
Regularity and adherence to the regimen are separate issues from circadian rhythm optimization. In multi-dose studies, biomarkers associated with NAD+ were evaluated over several days or weeks, and the observed changes may diminish after supplementation ends [4]. These results show that exposure over time matters for the studied biomarkers, but they should not be interpreted as evidence that sporadic differences in the timing of intake are harmful or that an exact time every day is necessary.
Based on current evidence, there is insufficient justification for designating a single universal morning or evening window as the optimal time for administration. Therefore, specific times should not be presented as a proven method for increasing efficacy unless supported by human studies on the specific formulation.
Limitations of current evidence
- Basic research demonstrating the circadian regulation of NAD+ and NAMPT has been conducted primarily on mice. An available human study measuring brain NAD levels at different times of day did not show a significant circadian difference in the analyzed parameter, which limits the possibility of directly translating the mechanism observed in animals into recommendations regarding the timing of supplementation in humans [1,2].
- No published human study has been identified that directly compares taking NAD+ precursors with food versus on an empty stomach to determine which method is better.
- No published human study has been identified that specifically evaluates the combination of an NAD+ precursor with resveratrol and compares different administration times. Evidence regarding the related compound, pterostilbene, should not be considered equivalent to evidence regarding resveratrol [3].
- Time of day, timing relative to meals, and timing relative to other supplements have generally not been analyzed as controlled variables in major studies on NAD+ precursors. This significantly limits the ability to formulate unambiguous, evidence-based recommendations.
- Evidence regarding a single NAD+ precursor, formulation, route of administration, dose, or studied population cannot be automatically generalized to other products or groups.
Disclaimer
The article is for educational and scientific-information purposes only. It does not constitute medical advice, a diagnosis, therapeutic recommendations, or a recommendation regarding the use of a supplement, injection, or combination of different substances.
NAD+, NAD+ precursors, resveratrol, and pterostilbene should not be presented as FDA- or EMA-approved treatments for diseases, unless referring to a specific approved medicinal product and indication. Changes in NAD+-related biomarkers do not in themselves constitute evidence of disease prevention, treatment, life extension, anti-aging effects, or other clinical benefits. A qualified healthcare professional should be consulted before taking supplements or combining them with medications, especially during pregnancy or breastfeeding and in the case of medical conditions requiring treatment.
References
[1] Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009). Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science, 324(5927), 654–657. https://doi.org/10.1126/science.1170803
[2] Cuenoud, B., Huang, Z., Hartweg, M., Widmaier, M., Lim, S., Wenz, D., & Xin, L. (2023). Effect of circadian rhythm on NAD and other metabolites in human brain. Frontiers in Physiology, 14, 1285776. https://doi.org/10.3389/fphys.2023.1285776
[3] Dellinger, R. W., Santos, S. R., Morris, M., Evans, M., Alminana, D., Guarente, L., & Marcotulli, E. (2017). Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: A randomized, double-blind, placebo-controlled study. npj Aging and Mechanisms of Disease, 3, 17. https://doi.org/10.1038/s41514-017-0016-9
[4] Berven, H., Svensen, M., Eikeland, H., Tvedten, N., Sheard, E. V., Amdahl Af Geijerstam, S., Søgnen, M., McCann, A., Arnsten, L., Årseth, O., Skjeie, V., Hjellbrekke, A., Skeie, G.-O., Torres Cleuren, Y. N., Nido, G. S., Haugarvoll, K., Riemer, F., Tzoulis, C., & Dölle, C. (2026). The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation. iScience, 29(3), 114764. https://doi.org/10.1016/j.isci.2026.114764
[5] Reyna, K., Heinzen, G., Patel, N., Ritter, M., Siojo, A., Legere, H., & Pojednic, R. (2026). Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): A retrospective tolerability pilot study in a real-world setting. Frontiers in Aging, 7, 1652582. https://doi.org/10.3389/fragi.2026.1652582